Fineline Cube

Follow:
14433 Articles
NMPA Approves Synaptic Medical's Cryoablation Device and Gene Methylation Detection Kit
CompanyMedical Device

NMPA Approves Synaptic Medical’s Cryoablation Device and Gene Methylation Detection Kit

Huadong Medicine's MediBeacon TGFR System Receives FDA Marketing Clearance
CompanyDrug

Huadong Medicine’s MediBeacon TGFR System Receives FDA Marketing Clearance

MediLink's YL201 Receives Breakthrough Therapy Designation for Nasopharyngeal Carcinoma
CompanyDrug

MediLink’s YL201 Receives Breakthrough Therapy Designation for Nasopharyngeal Carcinoma

Jiangsu Lianhuan Completes Enrollment for Phase III Study of LH-1801 in Type 2 Diabetes
CompanyDrug

Jiangsu Lianhuan Completes Enrollment for Phase III Study of LH-1801 in Type 2 Diabetes

Arrowhead's Plozasiran Accepted for FDA Review in Familial Chylomicronemia Syndrome
CompanyDrug

Arrowhead’s Plozasiran Accepted for FDA Review in Familial Chylomicronemia Syndrome

Keymed and InnoCare Announce Licensing Deal for CD20xCD3 Bispecific Antibody with Prolium
CompanyDeals

Keymed and InnoCare Announce Licensing Deal for CD20xCD3 Bispecific Antibody with Prolium

GSK's Jemperli Approved for First-Line Endometrial Cancer Treatment in EU
CompanyDrug

GSK’s Jemperli Approved for First-Line Endometrial Cancer Treatment in EU

Kelun-Biotech's Tagitanlimab Receives NMPA Clearance for Nasopharyngeal Carcinoma
CompanyDrug

Kelun-Biotech’s Tagitanlimab Receives NMPA Clearance for Nasopharyngeal Carcinoma

Junshi Biosciences Licenses Toripalimab to LEO Pharma for EU and UK Markets
CompanyDeals

Junshi Biosciences Licenses Toripalimab to LEO Pharma for EU and UK Markets

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2320 in AML
CompanyDrug

CARsgen Therapeutics Initiates Trial for Universal CAR-T Therapy KJ-C2320 in AML

Danaher Partners with Huashan Hospital to Develop Alzheimer's Diagnostic Solutions
CompanyDeals

Danaher Partners with Huashan Hospital to Develop Alzheimer’s Diagnostic Solutions

Chongqing Genrix's Xeligekimab Approved for Ankylosing Spondylitis by NMPA
CompanyDrug

Chongqing Genrix’s Xeligekimab Approved for Ankylosing Spondylitis by NMPA